Electronic versions of the materials you are seeking to access are being made available on this website in good faith and are for information purposes only.

These materials are not directed at or accessible by persons in the United States or persons resident or located in the United States, Australia, Canada, Japan, New Zealand, the Republic of South Africa, any EEA jurisdiction other than Ireland, Sweden and, to the extent that the necessary permissions have been granted, Denmark, or any other jurisdiction where the extension of availability of the materials to which you are seeking access would breach any applicable law or regulation.

Users of this website are responsible for observing all applicable laws and regulations in their relevant jurisdictions before proceeding to access the information contained herein. By proceeding to access the information, users are deemed to be representing and warranting that the applicable laws and regulations of their relevant jurisdiction allow them to do so.

By accessing this website you are representing to International Public Partnerships Limited (the "Company") and its advisers that the applicable laws of your relevant jurisdiction allow you to access this website and the material contained herein and in particular that you are not: (i) a US Person (within the meaning of Regulation S under the US Securities Act of 1933, as amended the "Securities Act") and are not acting on behalf of a US Person, nor purchasing with a view to re-sale in the US or to or for the account of a US Person, and that you are not an employee benefit plan subject to the United States Employee Retirement Income Security Act of 1974 and the regulations promulgated thereunder (in each case as amended) ("ERISA") or similar US laws or an individual retirement account as defined in section 408 of the US Internal Revenue Code; or (ii) a resident of Australia, Canada, Japan, New Zealand, the Republic of South Africa, any EEA jurisdiction other than Ireland, Sweden or, to the extent that the necessary permissions have been granted, Denmark or a jurisdiction where the extension of availability of the materials to which you are seeking access would breach any applicable law or regulation, and that you will not: (i) offer, sell, renounce, transfer or deliver, directly or indirectly, Shares subscribed for by you in (A) the United States, or (B) Australia, Canada, Japan, New Zealand, the Republic of South Africa, any EEA jurisdiction other than Ireland, Sweden or, to the extent that the necessary permissions have been granted, Denmark, or in any jurisdiction in which such offers or sales are unlawful ("Excluded Territories") or to any US Person or resident of any Excluded Territories, or: (ii) release or otherwise forward, distribute or send any materials on this website in or into the United States or any Excluded Territories.

Shares offered by the Company have not been and will not be registered under the Securities Act or with any securities regulatory authority of any State or other jurisdiction of the United States and, subject to certain exceptions, may not be offered or sold within the United States or to, or for the account or benefit of, US Persons (within the meaning of Regulation S under the Securities Act). The Company has not been and will not be registered as an "investment company" under the United States Investment Company Act of 1940 and investors will not be entitled to the benefits of that Act. In addition, relevant clearances have not been, and will not be, obtained from the securities commission (or equivalent) of any province of any Excluded Territories and, accordingly, unless an exemption under any relevant legislation or regulations is applicable, none of the Shares may be offered, sold, renounced, transferred or delivered, directly or indirectly, in any Excluded Territories.

Unless expressly indicated otherwise on a particular document or section of this website, the contents of this website are not a UK financial promotion and none of the contents of this website constitute an invitation or inducement to engage in investment activity. If and to the extent that this website or any of its contents are deemed to be a financial promotion, the Company is relying on the exemption provided by Article 69 of the UK Financial Services and Markets Act 2000 (Financial Promotions) Order 2005/1529 in respect of section 21 of the UK Financial Services and Markets Act 2000. In particular, any information in respect of past performance (including without limitation past performance of the Company, its group, shares in the Company and/or the Company’s portfolio) cannot be relied upon as a guide to future performance. None of the contents of this website are intended to be nor may they be considered as an investment recommendation nor personal advice.

The Company is a closed ended listed investment company which is incorporated in Guernsey and is recognised as a third country self-managed AIF in very limited EEA jurisdictions under the EU Alternative Investment Fund Managers Directive and in the UK under the UK Alternative Investment Fund Managers Regulations 2013 (SI 2013/1773). The Ordinary Shares of the Company are excluded from the UK FCA restrictions on promotion that are applicable in the UK to non-mainstream investment products, due to its current investment company structure.

Alternative Investment Fund Managers Regulations 2013 (SI 2013/1773).  The Ordinary Shares of the Company are excluded from the UK FCA restrictions on promotion that are applicable in the UK to non-mainstream investment products, due to its current investment company structure.

Any person accessing the website should carefully review the Terms of Use of the website. By using the website, you indicate that you accept the Terms of Use and that you agree to abide by them. If you do not agree to the Terms of Use, please refrain from using the website.

Please check the box below to confirm that:

  • You have read, understood and agree to the above;
  • You are not in the United States nor in any other jurisdiction where accessing this website may be prohibited by law or regulation;
  • You are not a US person or otherwise a resident of any Excluded Territory; and
  • You are not investing or otherwise acting for the account or benefit of a US person or a resident of any Excluded Territory.
Confirm
23 December 2021

International Public Partnerships Limited ('INPP' or 'the Company'), the FTSE 250 listed infrastructure investment company, is pleased to announce that it has agreed to acquire a small portfolio of UK PPP investments comprising initially interests in Townlands Community Hospital in Henley ('Townlands'), Eltham Community Hospital ('Eltham') and minority interests in the Building Schools for the Future ('BSF') projects STaG 1 and 2 ('STaG'). 

The interests will be acquired from an affiliate of the Company's Investment Adviser, Amber Infrastructure ('Amber'), for £3.1 million, following an independent valuation prepared by Newbridge Advisors LLP ('Newbridge'). Investment in minority interests in a further five BSF schemes from the same portfolio, representing up to £3.0 million of additional investment, will be made by the Company in the coming months.

The Townlands and Eltham projects were developed by Amber and are now at a level of operational maturity that fits the Company's risk appetite. The interests in the BSF projects were acquired by Amber from a member of the Carillion group of companies on the occasion of that group's financial collapse. At that time these particular interests (in contrast to other interests already owned by the Company) were judged not suitable for acquisition by the Company due to certain associated contingent liabilities. Following a significant piece of work involving re-negotiation and a restructure these contingent liabilities have been dealt with and accordingly the risks associated with them removed making them suitable for acquisition by the Company. All the assets in this portfolio are now performing well with either no or minimal operational issues. Overall, the portfolio is strongly yielding and delivers partially index-linked returns.

Details of the portfolio being acquired include:

  • Eltham is a community hospital project located in the London Borough of Greenwich that has been developed under the NHS LIFT framework with an availability-based revenue stream. Amber has been involved in the scheme since its inception and the team have overseen all aspects of project delivery, including design and development. The Company will acquire a 49.8% interest in the subordinated debt of the project.
  • Townlands is a community hospital scheme based in Henley-on-Thames which provides sub-acute care and comprises an ambulatory care centre and a palliative care centre. The project benefits from an availability-based revenue stream arising under a direct contract with the NHS. The Company will acquire a 100% interest in the equity and subordinated debt of Townlands.
  • STAG comprises education facilities in South Shields and Jarrow in the UK. The investment builds on the Company's existing portfolio of BSF projects, supporting the Company's commitment to providing a high-quality teaching environment to pupils across the portfolio. The Company will acquire a 8.00% interest in the project's subordinated debt and a 4.36% interest in the equity.

The Projects all contribute to a number of the UN's Sustainable Development Goals ('SDGs'). The investment in the management of healthcare centres and educational facilities acts in direct support of SDG 9 (Industry, Innovation and Infrastructure). The BSF investment directly contributes towards to SDG 4 (Quality Education) and schools also prepare young people for later life supporting SDG 8 (Decent Work and Economic Growth). Through their care provision, Eltham and Townlands contribute towards SDG 3 (Good Health and Well-Being).

Following financial close of the acquisition and draw down under the facility the Company will be approximately £163 million drawn against its £250 million corporate debt facility, including £9 million issued by way of a letter of credit to support the Company's commitment to invest in the Flinders University Health and Medical Research Building upon construction completion in March 2025.

Protocols provided in the Company's Investment Advisory Agreement been followed with respect to the sale of the Projects from Amber to INPP, including the establishment of separate buy side and sell side teams within Amber. Newbridge was engaged to provide an independent valuation opinion.

For further information:

Erica Sibree/Amy Edwards

T:+44 (0)20 7939 0558/0587
Amber Fund Management Limited
Hugh Jonathan

T: +44 (0)20 7260 1263
Numis Securities
Ed Berry/Mitch Barltrop

T: +44 (0)20 3727 1046/1039
FTI Consulting

About International Public Partnerships (INPP):

INPP is a listed infrastructure investment company that invests in global public infrastructure projects and businesses, which meets societal and environmental needs, both now, and into the future.

INPP is a responsible, long-term investor in over 130 infrastructure projects and businesses. The portfolio consists of utility and transmission, transport, education, health, justice and digital infrastructure projects and businesses, in the UK, Europe, Australia and North America. INPP seeks to provide its shareholders with both a long-term yield and capital growth.

Amber Infrastructure Group ('Amber') is the Investment Adviser to INPP and consists of over 150 staff who are responsible for the management of, advice on and origination of infrastructure investments.

Back to press releases